{"downloaded": true, "htmlmade": false, "full": {"id": "29374585", "source": "MED", "pmid": "29374585", "pmcid": "PMC5993578", "fullTextIdList": {"fullTextId": "PMC5993578"}, "doi": "10.1016/j.bbmt.2018.01.023", "title": "Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH Trial.", "authorString": "Shenoy S, Walters MC, Ngwube A, Soni S, Jacobsohn D, Chaudhury S, Grimley M, Chan K, Haight A, Kasow KA, Parikh S, Andreansky M, Connelly J, Delgado D, Godder K, Hale G, Nieder M, Pulsipher MA, Trachtenberg F, Neufeld E, Kwiatkowski JL, Thompson AA.", "authorList": {"author": [{"fullName": "Shenoy S", "firstName": "Shalini", "lastName": "Shenoy", "initials": "S", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, St. Louis Children's Hospital, Washington University, St. Louis, Missouri. Electronic address: shalinishenoy@wustl.edu."}}}, {"fullName": "Walters MC", "firstName": "Mark C", "lastName": "Walters", "initials": "MC", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, UCSF Benioff Children's Hospital, Oakland, California."}}}, {"fullName": "Ngwube A", "firstName": "Alex", "lastName": "Ngwube", "initials": "A", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, Phoenix Children's Hospital, Phoenix, Arizona."}}}, {"fullName": "Soni S", "firstName": "Sandeep", "lastName": "Soni", "initials": "S", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, Nationwide Children's Hospital, Columbus, Ohio; Department of Pediatrics, Lucile Packard Children's Hospital, Stanford University, Palo Alto, California."}}}, {"fullName": "Jacobsohn D", "firstName": "David", "lastName": "Jacobsohn", "initials": "D", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, Children's National Medical Center, Washington, DC."}}}, {"fullName": "Chaudhury S", "firstName": "Sonali", "lastName": "Chaudhury", "initials": "S", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University, Chicago, Illinois."}}}, {"fullName": "Grimley M", "firstName": "Michael", "lastName": "Grimley", "initials": "M", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, Texas Transplant Institute, San Antonio, Texas."}}}, {"fullName": "Chan K", "firstName": "Kawah", "lastName": "Chan", "initials": "K", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, Texas Transplant Institute, San Antonio, Texas."}}}, {"fullName": "Haight A", "firstName": "Ann", "lastName": "Haight", "initials": "A", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia."}}}, {"fullName": "Kasow KA", "firstName": "Kimberley A", "lastName": "Kasow", "initials": "KA", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina."}}}, {"fullName": "Parikh S", "firstName": "Suhag", "lastName": "Parikh", "initials": "S", "authorId": {"@type": "ORCID", "#text": "0000-0002-6066-9852"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, Duke University Medical Center, Durham, North Carolina."}}}, {"fullName": "Andreansky M", "firstName": "Martin", "lastName": "Andreansky", "initials": "M", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, University of Miami, Holtz Children's Hospital, Miami, Florida."}}}, {"fullName": "Connelly J", "firstName": "Jim", "lastName": "Connelly", "initials": "J", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, University of Michigan, Ann Arbor, Michigan."}}}, {"fullName": "Delgado D", "firstName": "David", "lastName": "Delgado", "initials": "D", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, Riley Children's Hospital, Indianapolis, Indiana."}}}, {"fullName": "Godder K", "firstName": "Kamar", "lastName": "Godder", "initials": "K", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, Nicklaus Children's Hospital, Miami, Florida."}}}, {"fullName": "Hale G", "firstName": "Gregory", "lastName": "Hale", "initials": "G", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, Johns Hopkins All Children's Hospital, St. Petersburg, Florida."}}}, {"fullName": "Nieder M", "firstName": "Michael", "lastName": "Nieder", "initials": "M", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, Johns Hopkins All Children's Hospital, St. Petersburg, Florida."}}}, {"fullName": "Pulsipher MA", "firstName": "Michael A", "lastName": "Pulsipher", "initials": "MA", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California."}}}, {"fullName": "Trachtenberg F", "firstName": "Felicia", "lastName": "Trachtenberg", "initials": "F", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, New England Research Institutes, Boston, Massachusetts."}}}, {"fullName": "Neufeld E", "firstName": "Ellis", "lastName": "Neufeld", "initials": "E", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, St. Jude Children's Research Hospital, Memphis, Tennessee."}}}, {"fullName": "Kwiatkowski JL", "firstName": "Janet L", "lastName": "Kwiatkowski", "initials": "JL", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania."}}}, {"fullName": "Thompson AA", "firstName": "Alexis A", "lastName": "Thompson", "initials": "AA", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pediatrics, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University, Chicago, Illinois."}}}]}, "authorIdList": {"authorId": {"@type": "ORCID", "#text": "0000-0002-6066-9852"}}, "journalInfo": {"issue": "6", "volume": "24", "journalIssueId": "2694485", "dateOfPublication": "2018 Jun", "monthOfPublication": "6", "yearOfPublication": "2018", "printPublicationDate": "2018-06-01", "journal": {"title": "Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation", "ISOAbbreviation": "Biol Blood Marrow Transplant", "medlineAbbreviation": "Biol Blood Marrow Transplant", "NLMid": "9600628", "ISSN": "1083-8791", "ESSN": "1523-6536"}}, "pubYear": "2018", "pageInfo": "1216-1222", "abstractText": "Allogeneic hematopoietic stem cell transplantation (HSCT) can cure transfusion-dependent thalassemia (TDT). In a multicenter trial we investigated the efficacy of reduced-intensity conditioning (RIC) before unrelated donor (URD) HSCT in children with TDT. Thirty-three children, ages 1 to 17 years, received bone marrow (BM) or umbilical cord blood (UCB) allografts. Median time to neutrophil engraftment was 13 days (range, 10 to 25) and 24 days (range, 18 to 49) and platelet engraftment 23 days (range, 12 to 46) and 50 days (range, 31 to 234) after BM and UCB allografts, respectively. With a median follow-up of 58 months (range, 7 to 79), overall and thalassemia-free survival was 82% (95% CI, .64% to .92%) and 79% (95% CI, .6% to .9%), respectively. The cumulative incidence of grades II to IV acute graft-versus-host disease (GVHD) after BM and UCB allografts was 24% and 44%; the 2-year cumulative incidence of chronic extensive GVHD was 29% and 21%, respectively; 71% of BM and 91% of UCB recipients discontinued systemic immunosuppression by 2 years. Six patients who had Pesaro risk class 2 (n\u2009=\u20095) and class 3 (n\u2009=\u20091) died of GVHD (n\u2009=\u20093), viral pneumonitis (n\u2009=\u20092) and pulmonary hemorrhage (n\u2009=\u20091). Outcomes after this RIC compared favorably with URD HSCT outcomes for TDT and supported engraftment in 32 of 33 patients. Efforts to reduce GVHD and infectious complications are being pursued further.", "affiliation": "Department of Pediatrics, St. Louis Children's Hospital, Washington University, St. Louis, Missouri. Electronic address: shalinishenoy@wustl.edu.", "publicationStatus": "ppublish", "language": "eng", "pubModel": "Print-Electronic", "pubTypeList": {"pubType": ["Clinical Trial", "Research Support, Non-U.S. Gov't", "research-article", "Multicenter Study", "Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"grantId": "U01 HL065238", "agency": "NHLBI NIH HHS", "acronym": "HL", "orderIn": "0"}, {"grantId": "U01 HL069254", "agency": "NHLBI NIH HHS", "acronym": "HL", "orderIn": "0"}]}, "meshHeadingList": {"meshHeading": [{"majorTopic_YN": "N", "descriptorName": "Fetal Blood", "meshQualifierList": {"meshQualifier": {"abbreviation": "TR", "qualifierName": "transplantation", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "Humans"}, {"majorTopic_YN": "N", "descriptorName": "Thalassemia", "meshQualifierList": {"meshQualifier": [{"abbreviation": "MO", "qualifierName": "mortality", "majorTopic_YN": "N"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "Y"}]}}, {"majorTopic_YN": "N", "descriptorName": "Graft vs Host Disease", "meshQualifierList": {"meshQualifier": {"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "Treatment Outcome"}, {"majorTopic_YN": "N", "descriptorName": "Transplantation Conditioning", "meshQualifierList": {"meshQualifier": {"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "Y"}}}, {"majorTopic_YN": "N", "descriptorName": "Bone Marrow Transplantation"}, {"majorTopic_YN": "N", "descriptorName": "Hematopoietic Stem Cell Transplantation", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}, {"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "Y"}]}}, {"majorTopic_YN": "N", "descriptorName": "Transplantation, Homologous", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "N"}, {"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}]}}, {"majorTopic_YN": "N", "descriptorName": "Survival Analysis"}, {"majorTopic_YN": "N", "descriptorName": "Adolescent"}, {"majorTopic_YN": "N", "descriptorName": "Child"}, {"majorTopic_YN": "N", "descriptorName": "Child, Preschool"}, {"majorTopic_YN": "N", "descriptorName": "Infant"}, {"majorTopic_YN": "N", "descriptorName": "Female"}, {"majorTopic_YN": "N", "descriptorName": "Male"}, {"majorTopic_YN": "Y", "descriptorName": "Unrelated Donors"}, {"majorTopic_YN": "N", "descriptorName": "Infections", "meshQualifierList": {"meshQualifier": {"abbreviation": "ET", "qualifierName": "etiology", "majorTopic_YN": "N"}}}]}, "keywordList": {"keyword": ["Thalassemia", "Hematopoietic Stem Cell Transplant", "Unrelated Donor", "Reduced-intensity Conditioning"]}, "subsetList": {"subset": {"code": "IM", "name": "Index Medicus"}}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.1016/j.bbmt.2018.01.023"}, {"availability": "Free", "availabilityCode": "F", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC5993578"}, {"availability": "Free", "availabilityCode": "F", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC5993578?pdf=render"}, {"availability": "Free", "availabilityCode": "F", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.1016/j.bbmt.2018.01.023"}]}, "commentCorrectionList": {"commentCorrection": {"id": "29704543", "source": "MED", "reference": "Biol Blood Marrow Transplant. 2018 Jun;24(6):1107-1108", "type": "Comment in", "orderIn": "1"}}, "isOpenAccess": "N", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "N", "citedByCount": "5", "hasData": "N", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "N", "authMan": "Y", "epmcAuthMan": "N", "nihAuthMan": "Y", "manuscriptId": "NIHMS937688", "hasTMAccessionNumbers": "N", "dateOfCompletion": "2019-04-01", "dateOfCreation": "2018-01-29", "firstIndexDate": "2018-01-29", "fullTextReceivedDate": "2020-10-21", "dateOfRevision": "2021-01-09", "electronicPublicationDate": "2018-01-31", "firstPublicationDate": "2018-01-31", "embargoDate": "2019-06-01"}, "abstract": "Allogeneic hematopoietic stem cell transplantation (HSCT) can cure transfusion-dependent thalassemia (TDT). In a multicenter trial we investigated the efficacy of reduced-intensity conditioning (RIC) before unrelated donor (URD) HSCT in children with TDT. Thirty-three children, ages 1 to 17 years, received bone marrow (BM) or umbilical cord blood (UCB) allografts. Median time to neutrophil engraftment was 13 days (range, 10 to 25) and 24 days (range, 18 to 49) and platelet engraftment 23 days (range, 12 to 46) and 50 days (range, 31 to 234) after BM and UCB allografts, respectively. With a median follow-up of 58 months (range, 7 to 79), overall and thalassemia-free survival was 82% (95% CI, .64% to .92%) and 79% (95% CI, .6% to .9%), respectively. The cumulative incidence of grades II to IV acute graft-versus-host disease (GVHD) after BM and UCB allografts was 24% and 44%; the 2-year cumulative incidence of chronic extensive GVHD was 29% and 21%, respectively; 71% of BM and 91% of UCB recipients discontinued systemic immunosuppression by 2 years. Six patients who had Pesaro risk class 2 (n\u2009=\u20095) and class 3 (n\u2009=\u20091) died of GVHD (n\u2009=\u20093), viral pneumonitis (n\u2009=\u20092) and pulmonary hemorrhage (n\u2009=\u20091). Outcomes after this RIC compared favorably with URD HSCT outcomes for TDT and supported engraftment in 32 of 33 patients. Efforts to reduce GVHD and infectious complications are being pursued further.", "Keywords": ["Thalassemia", "Hematopoietic Stem Cell Transplant", "Unrelated Donor", "Reduced-intensity Conditioning"], "journaltitle": "Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation", "authorinfo": ["Shenoy S", "Walters MC", "Ngwube A", "Soni S", "Jacobsohn D", "Chaudhury S", "Grimley M", "Chan K", "Haight A", "Kasow KA", "Parikh S", "Andreansky M", "Connelly J", "Delgado D", "Godder K", "Hale G", "Nieder M", "Pulsipher MA", "Trachtenberg F", "Neufeld E", "Kwiatkowski JL", "Thompson AA"], "title": "Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH Trial."}